Clinically, TNBCs are defined by their lack of expression of the oestrogen receptor α (ERα), progesterone receptor (PR) and HER2 (ERBB2), are generally of high histological grade, poorly differentiated and more aggressive compared to other subtypes of breast cancer (Griffiths & Olin, 2012). The gene discussed is PGR; the disease is breast carcinoma.